Clin2
NCT07126145Possibly a fitNot yet recruiting

Autoinflammatory Disease Long-term Study

Still DiseaseAutoinflammatory Disease

Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.

This study will follow people with adult-onset Still's disease or similar autoinflammatory conditions to learn more about these illnesses over time. By participating, you can help doctors better understand and treat these conditions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You have been diagnosed with adult-onset Still's disease or another autoinflammatory disease.
  • You are between 18 and 75 years old.
  • You are willing to come for all scheduled study visits and follow instructions.
  • You do not have other connective tissue diseases or certain autoantibodies in your blood.
  • You do not have a current infection, history of tuberculosis, drug allergies, or cancer.
  • You are not pregnant or planning to become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05927454Recruiting
RaDiCo Acostill study for inflammatory fevers and arthritis

This is a long-term study that collects health information and lab samples from people who have certain diagnoses of recurring (coming and going) inflammatory fevers and related joint or immune conditions. It may help researchers better understand these diseases and how they work over time.

Paris, Île-de-France Region
NCT06971289Not yet recruiting
Studying immune system activity in rare autoinflammatory diseases

This study looks at how the immune system works in people with rare autoinflammatory diseases. The goal is to develop tests that can help doctors better understand and treat these conditions.

NCT07625384Not yet recruiting· Phase 3
Testing Two Drugs for Adult-Onset Still's Disease

This study tests whether two injectable medicines (goflikicept and olokizumab) work safely as a second treatment for adults with Still's disease, a rare inflammatory condition. If you've already tried one treatment without enough improvement, this trial may help.

Izhevsk
NCT07150000Recruiting
Rheumatic disease research study for patients and healthy volunteers

This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.

Bonn, North Rhine-Westphalia
NCT05670301Recruiting
Blood test study to profile inflammation biomarkers in diseases

This study measures blood “biomarkers” (signals in blood) to better understand inflammatory diseases, including autoimmune and autoinflammatory conditions. You may be asked to give blood samples now and possibly extra samples if needed for testing.

Antwerp
NCT06354322Recruiting
Genetic study for unclassified autoinflammatory disease or AA amyloidosis

This study looks for genetic causes of hard-to-diagnose autoinflammatory diseases or a related condition called AA amyloidosis. It aims to find answers for people whose condition does not fit any known type, by studying their genes and medical history.

Paris

Hear when a new Still Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.